T. Rowe Price Associates
SLDB icon

T. Rowe Price Associates’s Solid Biosciences SLDB Stock Holding History

T. Rowe Price Associates’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$291K Buy
40,347
+5,260
+15% +$33.8K ﹤0.01% 2694
2025
Q4 		$198K Hold
35,087
– – ﹤0.01% 2814
2025
Q3 		$217K Buy
35,087
+2,010
+6% +$11.8K ﹤0.01% 2761
2025
Q2 		$162K Buy
33,077
+21,519
+186% +$76.1K ﹤0.01% 2783
2025
Q1 		$43K Buy
+11,558
New +$49.5K ﹤0.01% 2948
2021
Q4 		– Sell
-272,557
Closed -$9.77M – 3034
2021
Q3 		$9.77M Sell
272,557
-655
-0.2% -$27.8K ﹤0.01% 1421
2021
Q2 		$15M Sell
273,212
-7,388
-3% -$488K ﹤0.01% 1364
2021
Q1 		$23.3M Buy
+280,600
New +$31M ﹤0.01% 1243

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return